← All Signals

🏥 FDA: Wizcure Pharmaa Private Limited — Class II

healthcarebearishSource: FDA
88%Confidence
0Views
FDASource
2026-03-14Date

Summary

Vista Tears eye drops recalled due to lack of sterility assurance from Omni Lens, impacting dry eye relief product availability. This further implicates Omni Lens's manufacturing processes, suggesting broader compliance failures across its product lines.

Actionable: Review procurement of lubricant eye drops from Omni Lens and consider switching to suppliers with stronger quality records.

AI Confidence: 88%

Data Points

firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, Lubricant Drops, Sterile 10 ml (1/3 fl. oz.), Manuf

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now